Recent advances in Multi-Drug Resistance (MDR) efflux pump inhibitors of Gram-positive bacteria S. aureus

Antibiotics

Volumn 2, Issue 1, 2013, Pages 28-45

  Handzlik, Jadwiga ^a   Matys, Anna ^a   Kieć Kononowicz, Katarzyna ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Bacterial multidrug resistance; Efflux pump inhibitors; EPIs; MDR; NorA

Indexed keywords

CHALCONE; CIPROFLOXACIN; NORFLOXACIN; SEROTONIN UPTAKE INHIBITOR; SPARFLOXACIN;

CHEMICAL MODIFICATION; DOWN REGULATION; EFFUSION; HYDROLYSIS; IC 50; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVIEW; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84953271631     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics2010028     Document Type: Review

References (71)

1. Fournier Dit Chabert, J.; Marquez, B.; Neville, L.; Joucla, L.; Broussous, S.; Bouhours, P.; David, E.; Pellet-Rostaing, S.; Marquet, B.; Moreau, N.; et al. Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Bioorg. Med. Chem. 2007, 15, 4482-4497.
2. Bush, K.; Miller, G. H. Bacterial enzymatic resistance: Beta-lactamases and aminoglycoside-modifying enzymes. Curr. Opin. Microbiol. 1998, 1, 509-515.
3. Sabatini, S.; Gosetto, F.; Serritella, S.; Manfroni, G.; Tabarrini, O.; Iraci, N.; Brincat, J. P.; Carosati, E.; Villarini, M.; Kaatz, G. W.; et al. Pyrazolo[4, 3-c][1, 2]benzothiazines 5, 5-dioxide: A promising new class of Staphylococcus aureus NorA efflux pump inhibitors. J. Med. Chem. 2012, 55, 3568-3572.
4. Ruiz, J. Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 2003, 51, 1109-1117.
5. Nikaido, H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 2003, 67, 593-656.
6. Li, X. Z.; Nikaido, H. Efflux-mediated drug resistance in bacteria: An update. Drugs 2009, 69, 1555-1623.
7. Kohler, T.; Pechere, J. C.; Plesiat, P. Bacterial antibiotic efflux systems of medical importance. Cell Mol. Life Sci. 1999, 56, 771-778.
8. Mahamoud, A.; Chevalier, J.; Alibert-Franco, S.; Kern, W. V.; Pages, J. M. Antibiotic efflux pumps in Gram-negative bacteria: The inhibitor response strategy. J. Antimicrob. Chemother. 2007, 59, 1223-1229.
9. Poole, K.; Lomovskaya, O. Can efflux inhibitors really counter resistance? Drug Discov. Today 2006, 3, 145-152.
10. Michalet, S.; Cartier, G.; David, B.; Mariotte, A. M.; Dijoux-franca, M. G.; Kaatz, G. W.; Stavri, M.; Gibbons, S. N-Caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors. Bioorg. Med. Chem. Lett. 2007, 17, 1755-1758.
11. Mahamoud, A.; Chevalier, J.; Davin-Regli, A.; Barbe, J.; Pages, J. M. Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates. Curr. Drug Targets 2006, 7, 843-847.
12. Pages, J. M.; Amaral, L.; Fanning, S. An original deal for new molecule: Reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria. Curr. Med. Chem. 2011, 18, 2969-2980.
13. Pages, J. M.; Amaral, L. Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria. Biochim. Biophys. Acta 2009, 1794, 826-833.
14. Martins, M.; Dastidar, S. G.; Fanning, S.; Kristiansen, J. E.; Molnar, J.; Pages, J. M.; Schelz, Z.; Spengler, G.; Viveiros, M.; Amaral, L. Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: Mechanisms for their direct and indirect activities. Int. J. Antimicrob. Agents 2008, 31, 198-208.
15. Nikaido, H.; Pages, J. M. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol. Rev. 2012, 36, 340-363.
16. Bolla, J. M.; Alibert-Franco, S.; Handzlik, J.; Chevalier, J.; Mahamoud, A.; Boyer, G.; Kiec-Kononowicz, K.; Pages, J. M. Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria. FEBS Lett. 2011, 585, 1682-1690.
17. Handzlik, J.; Szymanska, E.; Chevalier, J.; Otrebska, E.; Kiec-Kononowicz, K.; Pages, J. M.; Alibert, S. Amine-alkyl derivatives of hydantoin: New tool to combat resistant bacteria. Eur. J. Med. Chem. 2011, 46, 5807-5816.
18. Handzlik, J.; Szymanska, E.; Alibert, S.; Chevalier, J.; Otrebska, E.; Pekala, E.; Pages, J. M.; Kiec-Kononowicz, K. Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin. Bioorg. Med. Chem. 2013, 21, 135-145.
19. Pradel, E.; Pages, J. M. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob. Agents Chemother. 2002, 46, 2640-2643.
20. Ghisalberti, D.; Masi, M.; Pages, J. M.; Chevalier, J. Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem. Biophys. Res. Commun. 2005, 328, 1113-1118.
21. Lavigne, J. P.; Sotto, A.; Nicolas-Chanoine, M. H.; Bouziges, N.; Bourg, G.; Davin-Regli, A.; Pages, J. M. Membrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates. Clin. Microbiol. Infect. 2012, 18, 539-545.
22. Askoura, M.; Mottawea, W.; Abujamel, T.; Taher, I. Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa. Libyan J. Med. 2011, 6, doi: 10. 3402/ljm. v6i0. 5870.
23. Drew, D.; Klepsch, M. M.; Newstead, S.; Flaig, R.; De Gier, J. W.; Iwata, S.; Beis, K. The structure of the efflux pump AcrB in complex with bile acid. Mol. Membr. Biol. 2008, 25, 677-682.
24. Sennhauser, G.; Bukowska, M. A.; Briand, C.; Grutter, M. G. Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa. J. Mol. Biol. 2009, 389, 134-145.
25. Pages, J. M.; Sandrine, A. F.; Mahamoud, A.; Bolla, J. M.; Davin-Regli, A.; Chevalier, J.; Garnotel, E. Efflux pumps of gram-negative bacteria, a new target for new molecules. Curr. Top. Med. Chem. 2010, 10, 1848-1857.
26. Ambrus, J. I.; Kelso, M. J.; Bremner, J. B.; Ball, A. R.; Casadei, G.; Lewis, K. Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus. Bioorg. Med. Chem. Lett. 2008, 18, 4294-4297.
27. Brincat, J. P.; Carosati, E.; Sabatini, S.; Manfroni, G.; Fravolini, A.; Raygada, J. L.; Patel, D.; Kaatz, G. W.; Cruciani, G. Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. J. Med. Chem. 2011, 54, 354-365.
28. Holler, J. G.; Slotved, H. C.; Molgaard, P.; Olsen, C. E.; Christensen, S. B. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles. Bioorg. Med. Chem. 2012, 20, 4514-4521.
29. Thota, N.; Koul, S.; Reddy, M. V.; Sangwan, P. L.; Khan, I. A.; Kumar, A.; Raja, A. F.; Andotra, S. S.; Qazi, G. N. Citral derived amides as potent bacterial NorA efflux pump inhibitors. Bioorg. Med. Chem. 2008, 16, 6535-6543.
30. Thota, N.; Reddy, M. V.; Kumar, A.; Khan, I. A.; Sangwan, P. L.; Kalia, N. P.; Koul, J. L.; Koul, S. Substituted dihydronaphthalenes as efflux pump inhibitors of Staphylococcus aureus. Eur. J. Med. Chem. 2010, 45, 3607-3616.
31. Samosorn, S.; Bremner, J. B.; Ball, A.; Lewis, K. Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors. Bioorg. Med. Chem. 2006, 14, 857-865.
32. Sangwan, P. L.; Koul, J. L.; Koul, S.; Reddy, M. V.; Thota, N.; Khan, I. A.; Kumar, A.; Kalia, N. P.; Qazi, G. N. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors. Bioorg. Med. Chem. 2008, 16, 9847-9857.
33. Nargotra, A.; Sharma, S.; Koul, J. L.; Sangwan, P. L.; Khan, I. A.; Kumar, A.; Taneja, S. C.; Koul, S. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors. Eur. J. Med. Chem. 2009, 44, 4128-4135.
34. Sabatini, S.; Gosetto, F.; Manfroni, G.; Tabarrini, O.; Kaatz, G. W.; Patel, D.; Cecchetti, V. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. J. Med. Chem. 2011, 54, 5722-5736.
35. Wei, P.; Kaatz, G. W.; Kerns, R. J. Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps. Bioorg. Med. Chem. Lett. 2004, 14, 3093-3097.
36. Abulrob, A. N.; Suller, M. T.; Gumbleton, M.; Simons, C.; Russell, A. D. Identification and biological evaluation of grapefruit oil components as potential novel efflux pump modulators in methicillin-resistant Staphylococcus aureus bacterial strains. Phytochemistry 2004, 65, 3021-3027.
37. German, N.; Kaatz, G. W.; Kerns, R. J. Synthesis and evaluation of PSSRI-based inhibitors of Staphylococcus aureus multidrug efflux pumps. Bioorg. Med. Chem. Lett. 2008, 18, 1368-1373.
38. Okandeji, B. O.; Greenwald, D. M.; Wroten, J.; Sello, J. K. Synthesis and evaluation of inhibitors of bacterial drug efflux pumps of the major facilitator superfamily. Bioorg. Med. Chem. 2011, 19, 7679-7689.
39. Jarmula, A.; Oblak, E.; Wawrzycka, D.; Gutowicz, J. Efflux-mediated antimicrobial multidrug resistance. Postepy Hig. Med. Dosw. (Online) 2011, 65, 216-227.
40. Li, X. Z.; Nikaido, H. Efflux-mediated drug resistance in bacteria. Drugs 2004, 64, 159-204.
41. Tseng, T. T.; Gratwick, K. S.; Kollman, J.; Park, D.; Nies, D. H.; Goffeau, A.; Saier, M. H., Jr. The RND permease superfamily: An ancient, ubiquitous and diverse family that includes human disease and development proteins. J. Mol. Microbiol. Biotechnol. 1999, 1, 107-125.
42. Truong-Bolduc, Q. C.; Dunman, P. M.; Strahilevitz, J.; Projan, S. J.; Hooper, D. C. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J. Bacteriol. 2005, 187, 2395-2405.
43. DeMarco, C. E.; Cushing, L. A.; Frempong-Manso, E.; Seo, S. M.; Jaravaza, T. A.; Kaatz, G. W. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 2007, 51, 3235-3239.
44. Huang, J.; O'Toole, P. W.; Shen, W.; Amrine-Madsen, H.; Jiang, X.; Lobo, N.; Palmer, L. M.; Voelker, L.; Fan, F.; Gwynn, M. N.; et al. Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus. Antimicrob. Agents Chemother. 2004, 48, 909-917.
45. Kaatz, G. W.; McAleese, F.; Seo, S. M. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob. Agents Chemother. 2005, 49, 1857-1864.
46. Piddock, L. J. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 2006, 19, 382-402.
47. Pozzi, G.; Iannelli, F.; Oggioni, M. R.; Santagati, M.; Stefani, S. Genetic elements carrying macrolide efflux genes in streptococci. Curr. Drug Targets Infect. Disord. 2004, 4, 203-206.
48. Reynolds, E.; Ross, J. I.; Cove, J. H. Msr(A) and related macrolide/streptogramin resistance determinants: incomplete transporters? Int. J. Antimicrob. Agents 2003, 22, 228-236.
49. Portillo, A.; Ruiz-Larrea, F.; Zarazaga, M.; Alonso, A.; Martinez, J. L.; Torres, C. Macrolide resistance genes in Enterococcus spp. Antimicrob. Agents Chemother. 2000, 44, 967-971.
50. Schwarz, S.; Kehrenberg, C.; Doublet, B.; Cloeckaert, A. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol. Rev. 2004, 28, 519-542.
51. Robertson, G. T.; Doyle, T. B.; Lynch, A. S. Use of an efflux-deficient streptococcus pneumoniae strain panel to identify ABC-class multidrug transporters involved in intrinsic resistance to antimicrobial agents. Antimicrob. Agents Chemother. 2005, 49, 4781-4783.
52. Yoshida, H.; Bogaki, M.; Nakamura, S.; Ubukata, K.; Konno, M. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 1990, 172, 6942-6949.
53. Pumbwe, L.; Piddock, L. J. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol. Lett. 2002, 206, 185-189.
54. Kehrenberg, C.; Schwarz, S. fexA, a novel Staphylococcus lentus gene encoding resistance to florfenicol and chloramphenicol. Antimicrob. Agents Chemother. 2004, 48, 615-618.
55. Borges-Walmsley, M. I.; McKeegan, K. S.; Walmsley, A. R. Structure and function of efflux pumps that confer resistance to drugs. Biochem. J. 2003, 376, 313-338.
56. Borges-Walmsley, M. I.; Walmsley, A. R. The structure and function of drug pumps. Trends Microbiol. 2001, 9, 71-79.
57. Paulsen, I. T.; Brown, M. H.; Skurray, R. A. Proton-dependent multidrug efflux systems. Microbiol. Rev. 1996, 60, 575-608.
58. Poole, K. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 2005, 56, 20-51.
59. Markham, P. N.; Neyfakh, A. A. Efflux-mediated drug resistance in Gram-positive bacteria. Curr. Opin. Microbiol. 2001, 4, 509-514.
60. Kikukawa, T.; Nara, T.; Araiso, T.; Miyauchi, S.; Kamo, N. Two-component bacterial multidrug transporter, EbrAB: Mutations making each component solely functional. Biochim. Biophys. Acta 2006, 1758, 673-679.
61. Putman, M.; van Veen, H. W.; Konings, W. N. Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev. 2000, 64, 672-693.
62. Wasaznik, A.; Grinholc, M.; Bielawski, K. P. Active efflux as the multidrug resistance mechanism. Postepy Hig. Med. Dosw. (Online) 2009, 63, 123-133.
63. Omote, H.; Hiasa, M.; Matsumoto, T.; Otsuka, M.; Moriyama, Y. The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations. Trends Pharmacol. Sci. 2006, 27, 587-593.
64. Van Bambeke, F.; Balzi, E.; Tulkens, P. M. Antibiotic efflux pumps. Biochem. Pharmacol. 2000, 60, 457-470.
65. Kumar, A.; Schweizer, H. P. Bacterial resistance to antibiotics: Active efflux and reduced uptake. Adv. Drug Deliv. Rev. 2005, 57, 1486-1513.
66. Lubelski, J.; Konings, W. N.; Driessen, A. J. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol. Mol. Biol. Rev. 2007, 71, 463-476.
67. Zgurskaya, H. I.; Nikaido, H. Multidrug resistance mechanisms: Drug efflux across two membranes. Mol. Microbiol. 2000, 37, 219-225.
68. Wang, K.; Pei, H.; Huang, B.; Zhu, X.; Zhang, J.; Zhou, B.; Zhu, L.; Zhang, Y.; Zhou, F. F. The Expression of ABC Efflux Pump, Rv1217c-Rv1218c, and Its Association with Multidrug Resistance of Mycobacterium tuberculosis in China. Curr. Microbiol. 2013, 66, 222-226.
69. Zechini, B.; Versace, I. Inhibitors of multidrug resistant efflux systems in bacteria. Recent. Pat. Antiinfect. Drug Discov. 2009, 4, 37-50.
70. Holler, J. G.; Christensen, S. B.; Slotved, H. C.; Rasmussen, H. B.; Guzman, A.; Olsen, C. E.; Petersen, B.; Molgaard, P. Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees. J. Antimicrob. Chemother. 2012, 67, 1138-1144.
71. ClinicalTrials. gov. A service of the US National Institutes of Health. Available online: www. clinicaltrials. gov (accessed on 31 January 2013).